“miniPCR™ is revolutionizing the way scientists, doctors and, for the first time, high school students engage with DNA analysis,” said Dr. Sebastian Kraves, Amplyus co-founder. “Our work on Genes in Space™ opens the doors to advanced biomedical experimentation in UAE classrooms.”
Amplyus, based at the Harvard Launch Lab, first designed, built, and tested the miniPCR™ System in 2014. Early adopters of the Kickstarter-funded instrument include researchers and clinicians in extreme global locations who take advantage of its portability and low energy requirements. Cambridge University professor Ian Goodfellow used miniPCR™ in Sierra Leone as part of a sequencing workflow for Ebola. Elaine Guevara of Yale University used it in Madagascar to study genetic diversity in rare lemur populations, using solar power.
The founders’ strong focus on education has led the company to forge partnerships with leading academic institutions. “It’s incredibly affordable, allows for students to have direct, hands-on experience and takes away part of the mysterious ‘black-box effect’ that tends to overshadow the science of DNA analysis,” said Alia Qatarneh of the Life Sciences Outreach Program at Harvard University.
“We are proud of our partnerships to promote STEM education,” added Dr. Ezequiel Alvarez Saavedra, Amplyus co-founder. “Through Genes in Space™ we work closely with educators to provide innovative professional development opportunities, equipment, and supplies to promote authentic research in schools.”
Headquartered in Cambridge, Massachusetts, Amplyus is led by a team of scientists engaged in the research, design, development and manufacture of advanced scientific technology systems. www.miniPCR.com
Media Contact: Sebastian Kraves, (781) 990-8727